Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bone metastasis site, specifically targeted via calcium-mimetic uptake, represents the unique microenvironment of bone tissue that attracts and supports metastatic cancer cells. This involves an interplay of molecules like the Calcium-Sensing Receptor (CaSR), P2X Receptor, TRPV6 Channel, TRPM7 Channel and SK3 Channel that recognize or exploit the high extracellular calcium concentrations characteristic of bone. These interactions promote tumor cell migration, proliferation, and survival within the bone, leading to a self-perpetuating cycle of bone destruction and tumor growth. Therapeutic strategies, such as the use of radium-223 dichloride (a calcium mimetic), exploit this mechanism to target and treat bone metastases.
Calcium mimetic; targets areas of increased bone turnover
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bone metastasis site (via calcium-mimetic uptake).